There are contraindications! Be sure to consult your doctor before taking any medication!

Relefact LH-RH

Relefact LH-RH - Relefact LH-RH is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary.

Indication: For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.

Relefact LH-RH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary. In the pituitary GnRH stimulates synthesis and release of FSH and LH, a process that is controlled by the frequency and amplitude of GnRH pulses, as well as the feedback of androgens and estrogens. The pulsatility of GnRH secretion has been seen in all vertebrates, and it is necessary to ensure a correct reproductive function. Thus a single hormone, GnRH, controls a complex process of follicular growth, ovulation, and corpus luteum maintenance in the female, and spermatogenesis in the male. Its short half life requires infusion pumps for its clinical use

Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products:

• Gonadorelin

Relefact LH-RH available forms, composition, doses:

• Injectable; Injection; Gonadorelin 0.1 mg / ml

Relefact LH-RH destination | category:

• Human:
• Gonadotropins
• Pituitary

Indications and usages, anatomical therapeutic chemical and diseases classification codes:

• H01CA01 - Gonadorelin
• V04CM01 - Gonadorelin

Pharmaceutical companies, researchers, developers, manufacturers, distributors and suppliers:

• Sanofi-Aventis